Bicarbonate in diabetic ketoacidosis - a systematic review

Horng Ruey Chua, Antoine Schneider, Rinaldo Bellomo, Horng Ruey Chua, Antoine Schneider, Rinaldo Bellomo

Abstract

Objective: This study was designed to examine the efficacy and risk of bicarbonate administration in the emergent treatment of severe acidemia in diabetic ketoacidosis (DKA).

Methods: PUBMED database was used to identify potentially relevant articles in the pediatric and adult DKA populations. DKA intervention studies on bicarbonate administration versus no bicarbonate in the emergent therapy, acid-base studies, studies on risk association with cerebral edema, and related case reports, were selected for review. Two reviewers independently conducted data extraction and assessed the citation relevance for inclusion.

Results: From 508 potentially relevant articles, 44 were included in the systematic review, including three adult randomized controlled trials (RCT) on bicarbonate administration versus no bicarbonate in DKA. We observed a marked heterogeneity in pH threshold, concentration, amount, and timing for bicarbonate administration in various studies. Two RCTs demonstrated transient improvement in metabolic acidosis with bicarbonate treatment within the initial 2 hours. There was no evidence of improved glycemic control or clinical efficacy. There was retrospective evidence of increased risk for cerebral edema and prolonged hospitalization in children who received bicarbonate, and weak evidence of transient paradoxical worsening of ketosis, and increased need for potassium supplementation. No studies involved patients with an initial pH < 6.85.

Conclusions: The evidence to date does not justify the administration of bicarbonate for the emergent treatment of DKA, especially in the pediatric population, in view of possible clinical harm and lack of sustained benefits.

Figures

Figure 1
Figure 1
Overview of study selection process.

References

    1. Durward A. In: Critical Care Nephrology. 2. Ronco C, Bellomo R, Kellum J, editor. Philadelphia: Saunders, Elsevier; 2009. Diabetic ketoacidosis; pp. 641–647. Acid-base problems.
    1. McGarry J, Wright PH, Foster DW. Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon. J Clin Invest. 1975;55:1202–1209. doi: 10.1172/JCI108038.
    1. McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem. 1980;49:395–420. doi: 10.1146/annurev.bi.49.070180.002143.
    1. Zimmet PZ, Taft P, Ennis GC, Sheath J. Acid production in diabetic acidosis; a more rational approach to alkali replacement. British Medical Journal. 1970;3:610–612. doi: 10.1136/bmj.3.5723.610.
    1. Calzavacca P, Lacari E, Bellomo R. In: Stewart's Textbook of Acid-Base. Ebers P, Kellum J , editor. 2009. Renal failure; pp. 394–395. Clinical applications of quantitative acid-base medicine.
    1. Oh MS, Carroll HJ, Goldstein DA, Fein IA. Hyperchloremic acidosis during the recovery phase of diabetic ketosis. Annals of Internal Medicine. 1978;89:925–927.
    1. Adrogue HJ, Wilson H, Boyd AE, Suki WN, Eknoyan G. Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med. 1982;307:1603–1610. doi: 10.1056/NEJM198212233072603.
    1. Foster DW, McGarry JD. The metabolic derangements and treatment of diabetic ketoacidosis. N Engl J Med. 1983;309:159–169. doi: 10.1056/NEJM198307213090307.
    1. Mitchell JH, Wildenthal K, Johnson RL Jr. The effects of acid-base disturbances on cardiovascular and pulmonary function. Kidney Int. 1972;1:375–389. doi: 10.1038/ki.1972.48.
    1. Kono N, Kuwajima M, Tarui S. Alteration of glycolytic intermediary metabolism in erythrocytes during diabetic ketoacidosis and its recovery phase. Diabetes. 1981;30:346–353. doi: 10.2337/diabetes.30.4.346.
    1. Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders. First of two parts. N Engl J Med. 1998;338:26–34. doi: 10.1056/NEJM199801013380106.
    1. Kraut JA, Kurtz I. Use of base in the treatment of severe acidemic states. American Journal of Kidney Diseases. 2001;38:703–727. doi: 10.1053/ajkd.2001.27688.
    1. Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. British Medical Journal Clinical Research Ed. 1984;289:1035–1038. doi: 10.1136/bmj.289.6451.1035.
    1. Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Annals of Internal Medicine. 1986;105:836–840.
    1. Gamba G, Oseguera J, Castrejon M, Gomez-Perez FJ. Bicarbonate therapy in severe diabetic ketoacidosis. A double blind, randomized, placebo controlled trial. Revista de Investigacion Clinica. 1991;43:234–238.
    1. Munk P, Freedman MH, Levison H, Ehrlich RM. Effect of bicarbonate on oxygen transport in juvenile diabetic ketoacidosis. Journal of Pediatrics. 1974;84:510–514. doi: 10.1016/S0022-3476(74)80669-4.
    1. Lutterman JA, Adriaansen AA, van 't Laar A. Treatment of severe diabetic ketoacidosis. A comparative study of two methods. Diabetologia. 1979;17:17–21. doi: 10.1007/BF01222972.
    1. Lever E, Jaspan JB. Sodium bicarbonate therapy in severe diabetic ketoacidosis. American Journal of Medicine. 1983;75:263–268. doi: 10.1016/0002-9343(83)91203-2.
    1. Okuda Y, Adrogue HJ, Field JB, Nohara H, Yamashita K. Counterproductive effects of sodium bicarbonate in diabetic ketoacidosis. Journal of Clinical Endocrinology & Metabolism. 1996;81:314–320. doi: 10.1210/jc.81.1.314.
    1. Viallon A, Zeni F, Lafond P, Venet C, Tardy B, Page Y, Bertrand JC. Does bicarbonate therapy improve the management of severe diabetic ketoacidosis? Critical Care Medicine. 1999;27:2690–2693. doi: 10.1097/00003246-199912000-00014.
    1. Latif KA, Freire AX, Kitabchi AE, Umpierrez GE, Qureshi N. The use of alkali therapy in severe diabetic ketoacidosis. Diabetes Care. 2002;25:2113–2114. doi: 10.2337/diacare.25.11.2113.
    1. Soler NG, Bennett MA, Dixon K, FitzGerald MG, Malins JM. Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate. Lancet. 1972;2:665–667.
    1. Assal JP, Aoki TT, Manzano FM, Kozak GP. Metabolic effects of sodium bicarbonate in management of diabetic ketoacidosis. Diabetes. 1974;23:405–411.
    1. Green SM, Rothrock SG, Ho JD, Gallant RD, Borger R, Thomas TL, Zimmerman GJ. Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis. Annals of Emergency Medicine. 1998;31:41–48. doi: 10.1016/S0196-0644(98)70279-3.
    1. Glaser N, Barnett P, McCaslin I, Nelson D, Trainor J, Louie J, Kaufman F, Quayle K, Roback M, Malley R. et al.Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. New England Journal of Medicine. 2001;344:264–269. doi: 10.1056/NEJM200101253440404.
    1. Lawrence SE, Cummings EA, Gaboury I, Daneman D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. Journal of Pediatrics. 2005;146:688–692. doi: 10.1016/j.jpeds.2004.12.041.
    1. Edge JA, Jakes RW, Roy Y, Hawkins M, Winter D, Ford-Adams ME, Murphy NP, Bergomi A, Widmer B, Dunger DB. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia. 2006;49:2002–2009. doi: 10.1007/s00125-006-0363-8.
    1. Edge JA, Roy Y, Bergomi A, Murphy NP, Ford-Adams ME, Ong KK, Dunger DB. Conscious level in children with diabetic ketoacidosis is related to severity of acidosis and not to blood glucose concentration. Pediatric Diabetes. 2006;7:11–15.
    1. Addis GJ, Thomson WS, Welch JD. BICARBONATE THERAPY IN DIABETIC ACIDOSIS. Lancet. 1964;2:223–225.
    1. Kuzemko JA, Fielding DW, Hudson FP. The management of acid-base balance in children with diabetic acidosis. Postgrad Med J. 1969;45:21–26. doi: 10.1136/pgmj.45.519.21.
    1. Krumlik JJ, Ehrlich RM. Insulin and sodium bicarbonate treatment of diabetic acidosis: a retrospective review. Journal of Pediatrics. 1973;83:269–271.
    1. Soler NG, Bennett MA, Fitzgerald MG, Malins JM. Successful resuscitation in diabetic ketoacidosis: a strong case for the use of bicarbonate. Postgraduate Medical Journal. 1974;50:465–468. doi: 10.1136/pgmj.50.585.465.
    1. Keller U, Berger W, Ritz R, Truog P. Course and prognosis of 86 episodes of diabetic coma. A five year experience with a uniform schedule of treatment. Diabetologia. 1975;11:93–100. doi: 10.1007/BF00429830.
    1. Reddy CM, Orti E. Insulin and sodium bicarbonate treatment in diabetic ketoacidosis in children. Journal of the National Medical Association. 1977;69:355–357.
    1. Kamarzaman Z, Turner C, Clark F. How low can you go: a case presentation on a patient with diabetic ketoacidosis. Resuscitation, Ireland. 2009;80:967–968.
    1. Guneysel O, Guralp I, Onur O. Bicarbonate therapy in diabetic ketoacidosis. Bratislavske Lekarske Listy. 2008;109:453–454.
    1. Mellemgaard K, Astrup P. The Quantitative Determination of Surplus Amounts of Acid or Base in the Human Body. Scandinavian Journal of Clinical & Laboratory Investigation. 1960;12:187–199. doi: 10.3109/00365516009062421.
    1. Astrup P, Jorgensen K, Andersen OS, Engel K. The acid-base metabolism. A new approach. Lancet. 1960;1:1035–1039.
    1. Ohman JL, Marliss EB, Aoki TT, Munichoodappa CS, Khanna VV, Kozak GP. The cerebrospinal fluid in diabetic ketoacidosis. N Engl J Med. 1971;284:283–290. doi: 10.1056/NEJM197102112840601.
    1. Troy PJ, Clark RP, Kakarala SG, Burns J, Silverman IE, Shore E. Cerebral edema during treatment of diabetic ketoacidosis in an adult with new onset diabetes. Neurocrit Care, United States. 2005;2:55–58.
    1. Hiller KM, Wolf SJ. Cerebral edema in an adult patient with diabetic ketoacidosis. Am J Emerg Med, United States. 2005;23:399–400.
    1. Haringhuizen A, Tjan DH, Grool A, van Vugt R, van Zante AR. Fatal cerebral oedema in adult diabetic ketoacidosis. Netherlands Journal of Medicine. 2010;68:35–37.
    1. Taylor D, Durward A, Tibby SM, Thorburn K, Holton F, Johnstone IC, Murdoch IA. The influence of hyperchloraemia on acid base interpretation in diabetic ketoacidosis. Intensive Care Med. 2006;32:295–301. doi: 10.1007/s00134-005-0009-1.
    1. Walker BG, Phear DN, Martin FI, Baird CW. INHIBITION OF INSULIN BY ACIDOSIS. Lancet. 1963;2:964–965.
    1. Ibrahim Eel D, McLellan SA, Walsh TS. Red blood cell 2,3-diphosphoglycerate concentration and in vivo P50 during early critical illness. Crit Care Med, United States. 2005;33:2247–2252.
    1. Alberti KG, Emerson PM, Darley JH, Hockaday TD. 2,3-Diphosphoglycerate and tissue oxygenation in uncontrolled diabetes mellitus. Lancet. 1972;2:391–395.
    1. Posner JB, Plum F. Spinal-fluid pH and neurologic symptoms in systemic acidosis. N Engl J Med. 1967;277:605–613. doi: 10.1056/NEJM196709212771201.
    1. Bohn D. Understanding the pathophysiology of cerebral edema in diabetic ketoacidosis: another brick in the wall? Pediatr Crit Care Med, United States. 2010;11:421–423.
    1. Glaser N. Cerebral injury and cerebral edema in children with diabetic ketoacidosis: could cerebral ischemia and reperfusion injury be involved? Pediatr Diabetes, Denmark. 2009;10:534–541. doi: 10.1111/j.1399-5448.2009.00511.x.
    1. Fitzgerald MG, O'Sullivan DJ, Malins JM. Fatal Diabetic Ketosis. Br Med J. 1961;1:247–250. doi: 10.1136/bmj.1.5221.247.
    1. Young E, Bradley RF. Cerebral edema with irreversible coma in severe diabetic ketoacidosis. N Engl J Med. 1967;276:665–669. doi: 10.1056/NEJM196703232761204.
    1. Taubin H, Matz R. Cerebral edema, diabetes insipidus, and sudden death during the treatment of diabetic ketoacidosis. Diabetes. 1968;17:108–109.
    1. Riley LJ, Cooper M, Narins RG. Alkali therapy of diabetic ketoacidosis: biochemical, physiologic, and clinical perspectives. Diabetes-Metabolism Reviews. 1989;5:627–636. doi: 10.1002/dmr.5610050801.
    1. Mahler SA, Conrad SA, Wang H, Arnold TC. Am J Emerg Med. Elsevier Inc; 2010. Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis.

Source: PubMed

3
Iratkozz fel